Looking Ahead to 2025 Dermatology Drug Approvals
Review our list below of dermatology Prescription Drug User Fee Act (PDUFA) goal dates to keep on your dermatologic radar this upcoming year. April 18, 2025: Dupilumab (Dupixent; Sanofi) for Chronic Spontaneous Urticaria In November, Regeneron …